Pansacala, Moises L.
HRN: 28-21-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2025
MEBENDAZOLE 500MG (TAB)
12/04/2025
12/11/2025
PO
500mg
Tid
E Histolytica/ Dispar Infection
Checking Final Appropriateness
12/04/2025
CEFTRIAXONE 1G (VIAL)
12/04/2025
12/11/2025
IV
2g
Od
Sepsis Sec To AGE
Checking Final Appropriateness